Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wauson, E. M.
Right arrow Articles by Vorce, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wauson, E. M.
Right arrow Articles by Vorce, R. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences 65, 211-219 (2002)
Copyright © 2002 by the Society of Toxicology

MOLECULAR AND GENETIC TOXICOLOGY

Sodium Arsenite Inhibits and Reverses Expression of Adipogenic and Fat Cell-Specific Genes during in Vitro Adipogenesis

Eric M. Wauson, Amy S. Langan and Roseann L. Vorce,1

Center for Environmental Toxicology and Department of Pharmacology, University of Nebraska Medical Center, Omaha, Nebraska 68198-6260

Arsenic causes cancer in humans, but its mechanism of action is unique among known carcinogenic agents. As a naturally occurring component of sediments and ground water, human exposure to arsenic is inevitable, necessitating the establishment of exposure limits. Because cancer is characterized as an imbalance between cell growth and differentiation, it has been hypothesized that arsenic exerts its carcinogenic effect, in part, by perturbing the balance between these antagonistic processes. Previous work in this laboratory has demonstrated that sodium arsenite prevents adipocytic differentiation of C3H 10T1/2 cells, leading to the hypothesis that the underlying mechanism involves downregulation of genes associated with adipogenesis. In support of this hypothesis, it was found that mRNA levels of peroxisome proliferative-activated receptor {gamma} (PPAR{gamma}), CCAAT-enhancer binding protein {alpha} (C/EBP{alpha}), and adipocyte-selective, fatty acid-binding protein (aP2) are decreased in arsenic-treated cells; arsenic-induced phenotypic reversion of differentiated adipocytes correlates with reduced aP2 expression. Arsenic also blocks upregulation of p21Cip1/Waf1, a factor whose expression is tightly regulated during adipogenesis. The differentiating effect of pioglitazone, which induces adipogenesis by activating PPAR{gamma}, is inhibited by arsenic, suggesting that arsenic interferes with adipogenic signaling at or below the level of PPAR{gamma}. Because C/EBP{alpha} is important in the expression of certain keratinocyte-specific genes, the negative effect of arsenic on C/EBP{alpha} might also contribute to the development of skin cancer. PPAR{gamma}, C/EBP{alpha}, and p21Cip1/Waf1 are important in numerous normal and pathological processes, including carcinogenesis, leading us to postulate that perturbation of these factors by arsenic might contribute to the carcinogenic effect of this metalloid.

Key Words: arsenic; differentiation; proliferation; cancer; adipocytes; adipogenesis; aP-2; PPAR{gamma}, C/EBP{alpha}, p21Cip1/Waf1.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JAMAHome page
A. Navas-Acien, E. K. Silbergeld, R. Pastor-Barriuso, and E. Guallar
Arsenic Exposure and Prevalence of Type 2 Diabetes in US Adults
JAMA, August 20, 2008; 300(7): 814 - 822.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
K. Nohara, K. Ao, Y. Miyamoto, T. Suzuki, S. Imaizumi, Y. Tateishi, S. Omura, C. Tohyama, and T. Kobayashi
Arsenite-Induced Thymus Atrophy is Mediated by Cell Cycle Arrest: A Characteristic Downregulation of E2F-Related Genes Revealed by a Microarray Approach
Toxicol. Sci., February 1, 2008; 101(2): 226 - 238.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Lemarie, C. Morzadec, E. Bourdonnay, O. Fardel, and L. Vernhet
Human macrophages constitute targets for immunotoxic inorganic arsenic.
J. Immunol., September 1, 2006; 177(5): 3019 - 3027.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
D. M. Barnes, P. R. Hanlon, and E. A. Kircher
Effects of Inorganic HgCl2 on Adipogenesis
Toxicol. Sci., October 1, 2003; 75(2): 368 - 377.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. A. Rea, J. P. Gregg, Q. Qin, M. A. Phillips, and R. H. Rice
Global alteration of gene expression in human keratinocytes by inorganic arsenic
Carcinogenesis, April 1, 2003; 24(4): 747 - 756.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
K. Salnikow and M. D. Cohen
Backing into Cancer: Effects of Arsenic on Cell Differentiation
Toxicol. Sci., February 1, 2002; 65(2): 161 - 163.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.